ClinicalTrials.gg
CompletedNCT05543811Spread BogatyrUpdated Apr 11, 2023

The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology

An interventional study of Food for special dietary use in Cognitive Change, Memory; Disturbance, Mild and Emotional Regulation, sponsored by Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology. Completed at 1 site in Russian Federation. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-11.

Sponsored by Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Lymphoma, Follicular with a site in Russian Federation — none open to participants now, none under way, none of them phase 3. Lymphoma, Follicular · Russian Federation.

Enrollment
18th of 26
140 · median 274
Started
2022
the only one that year
No phase
Only one
of the 26
Registered
26th of 26
by date
Lead sponsor
1 of 26
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology

Among the 26 studies in Lymphoma, Follicular with a site in Russian Federation, this one is the 18th largest by enrollment, is the only one that started in 2022, is the only one with no phase, and was the 26th registered.

Lymphoma, Follicular

1,893 studies on the registry are indexed under Lymphoma, Follicular; 289 are open to participants now.

Browse Lymphoma, Follicular studies →

Open to participants now

None of the 26 studies in Lymphoma, Follicular with a site in Russian Federation is open now. The open studies under Lymphoma, Follicular, anywhere →

Who these studies take

Of the 226 Lymphoma, Follicular studies recruiting now, 158 (70%) set no upper age limit and 39 (17%) stop at 75 or younger; 34 take children under 18; 23 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 26 studies in Lymphoma, Follicular with a site in Russian Federation as a file.
02

Study summary

This is a single-centre, single-blind, two-arms, controlled study to assess the efficacy and safety of food for special dietary use enriched with 5-hydroxytryptophan, L-theanine and Gamma-aminobutyric acid in generally healthy subjects with no cognitive disturbances

03

Conditions studied

  • Cognitive Change
  • Memory; Disturbance, Mild
  • Emotional Regulation
  • Concentration Ability Impaired
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • willingness to participate;
  • age of 18-50 years

Exclusion criteria

Exclusion Criteria:

  • pregnancy or breastfeeding;
  • significant somatic or psychological disorders
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
140 participants (actual)

Study arms

  • Experimental
    Product for special dietary use

    Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid will be given to the subjects enrolled to this arm, 20 gram twice daily with breakfast and supper (instead of butter)

    Dietary Supplement: Food for special dietary use

  • Placebo comparator
    control

    This group will receive standard spread, without theanine, gamma-aminobutyric acid and 5-hydroxytryptophan, twice daily with breakfast and supper with food (instead of butter)

    Dietary Supplement: Food for special dietary use

Interventions

  • Dietary supplementFood for special dietary use

    Food for special dietary use (spread) with modified ingredients' content will be included to the diet of 70 patients without significant organic pathology for 14 days receiving standard diet, modified by the inclusion of two portions of the spread, 20 grams each for breakfast and dinner

06

What researchers measure

Primary outcomes

  1. change in cognitive function

    change in score by Lurie test

    Time frame: two weeks

  2. change in cognitive function2

    change in Kraepelin\&Schulte test score

    Time frame: two weeks

  3. change in functional status

    change in functional status test score

    Time frame: two weeks

  4. change in anxiety and depression

    change in Beck depression inventory score

    Time frame: two weeks

Secondary outcomes

  1. change in food's taste monotony

    change in food's taste monotony

    Time frame: two weeks

07

Study locations

1 site
  • Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
    Moscow, 115446, Russian Federation
08

References and documents

Individual participant data

Plan to share: Yes — Blinded individual participant data may be shared by reasonable request to primary investigator upon study completion

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: 2 years after study completion

Access criteria: reasonable request to primary investigator

Data sharing details ↗ · ion.ru

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2022 to primary completion in Dec 2022, 3 months.

Of 143 non-industry interventional studies with no phase under Lymphoma, Follicular, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 47. This study's 3 months is below that.

Counting every sponsor, half of 167 studies reached it within 27 months; a quarter within 13 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2022
First posted
Sep 16, 2022
StartActual
Sep 15, 2022
Primary completionActual
Dec 31, 2022
CompletionActual
Feb 28, 2023
Last update
Apr 11, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05543811
Lead sponsor
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Collaborators
Group of companies EFKO, Russian Science Foundation
Responsible party
Sponsor
First posted
Sep 16, 2022
Start date
Sep 15, 2022
Primary completion
Dec 31, 2022
Completion
Feb 28, 2023
Last update
Apr 11, 2023

Study contacts

Vasily Isakov, Professor
study chair · Federal Research Center of Nutrition and Biotechnology

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion